Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDT CORP Director's Dealing 2024

Dec 4, 2024

31854_dirs_2024-12-04_5a794cc7-b566-4136-9ba9-90abc105b472.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDT CORP (IDT)
CIK: 0001005731
Period of Report: 2024-12-02

Reporting Person: SILBERMAN MITCH (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-02 Class B Common Stock, par value $.01 per share A 1172 Acquired 1172 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-02 Deferred Stock Units $ A 2344 Acquired 2027-12-15 Class B Common Stock (2344) Direct

Footnotes

F1: Represents a grant of 1,172 restricted shares of Class B common stock ("Restricted Stock") that will vest, and vest in full, only if the Class B common stock closes at or above $72.50 per share for either the average of ten (10) trading days or the ten (10) consecutive trading days prior to October 15, 2027.

F2: Consists of 1,172 shares of Restricted Stock that will vest, and vest in full, only if the Class B common stock closes at or above $72.50 per share for either the average of ten (10) trading days or the ten (10) consecutive trading days prior to October 15, 2027.

F3: Represents a grant of 2,344 deferred stock units ("DSUs"). Each DSU is the right to receive between 1/2 of a share and 2 shares of the Issuer's Class B common stock. Vesting is in thirds on each of October 15, 2025, October 15, 2026 and October 15, 2027. The number of shares that will actually be issued for each DSU on the vesting date depends on the market price for the Class B common stock as of the relevant determination date. 1/2 of a share will be issued for each DSU if the market price on the determination date is less than $18.125 and 2 shares will be issued for each DSU if the market price on the determination date is $72.50 or greater, with the proprotionate amount to be issued based on thresholds of 62.5%, 75%, 87.5%, 100%, 112.5%, 125%, 137.5%, 150%, 162.5%, 175% and 187.5% of the grant date value ($36.25). Upon vesting in full, the Reporting Person will be entitiled to receive between 1,172 and 4,688 shares of Class B common stock.